Literature DB >> 10618778

[The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].

L de la Fuente1, M J Bravo, C Lew, G Barrio, V Soriano, L Royuela.   

Abstract

BACKGROUND: The switch from intravenous heroin administration to smoking of heroin might be changed the trends in the prevalence of HIV infection and risk behaviours among Spanish users. SUBJECTS AND METHODS: Cross-sectional study of 909 regular heroin users, recruited within and outside of drug treatment centres. The prevalence of HIV infection and risk behaviours were studied in the whole sample and among injectors.
RESULTS: The proportion of heroin users who had ever injected was 86.7% in Barcelona, 71.1% in Madrid and 56.1% in Seville, while the proportion of those who had injected in the last 30 days was 79.7, 35.6 and 29.2%, respectively. The prevalence of HIV infection among users who had ever injected was 46.2% in Barcelona, 39.6% in Madrid and 47.1% in Seville; in the total population of heroin users the prevalence was 40, 31.1 and 28%, respectively. Among current injectors, 10.9% in Barcelona, 13.9% in Madrid and 23.6% in Seville reported they had injected with used syringes in the last 30 days, while the corresponding proportion among the total population of users was 8.7, 4.9 and 6.9%, respectively. Moreover, 19.2% of injectors in Barcelona, 16.7% in Madrid and 16.9% in Seville admitted to injecting drugs which had been diluted in syringes previously used by others in the last 30 days; of this group, over half stated they had not injected with used syringes during that period.
CONCLUSIONS: The prevalence of HIV infection and risk behaviours among heroin users differs depending on whether all users or only injectors are considered. This suggests that the transition from injecting to smoking is one of the major factors contributing to the control of the HIV epidemic in Spain. This contribution, which has little to do with regional prevention policies, must be taken into account when comparing their effectiveness.

Entities:  

Mesh:

Year:  1999        PMID: 10618778

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  4 in total

1.  Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.

Authors:  Luis de la Fuente; María José Bravo; Carlos Toro; M Teresa Brugal; Gregorio Barrio; Vicente Soriano; Fernando Vallejo; Rosario Ballesta
Journal:  J Epidemiol Community Health       Date:  2006-06       Impact factor: 3.710

2.  Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.

Authors:  G Barrio; L De La Fuente; C Toro; T M Brugal; V Soriano; F Gonzalez; M J Bravo; F Vallejo; T C Silva
Journal:  Epidemiol Infect       Date:  2006-09-28       Impact factor: 2.451

3.  [Differential health and toxicological features of drug-dependents in treatment and in active consumption].

Authors:  C Navarro Cañadas; P Bachiller Luque; T Palacios Martín; P Ruiz Muñoz; M Herrero Baladrón; I Sánchez Lite
Journal:  Aten Primaria       Date:  2003-10-15       Impact factor: 1.137

4.  Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus.

Authors:  J Macías; J A Pineda; F Lozano; J E Corzo; A Ramos; E León; J A García-García; J Fernández-Rivera; J A Mira; J Gómez-Mateos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-23       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.